TR Corporation Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
23
- Latest Deal Type
-
Later Stage VC
- Investors
-
17
TR Corporation General Information
Description
Operator of a smart healthcare and medical technology company intended for early disease detection and therapeutic support. The company offers artificial intelligence-based respiratory disease testing, compression bands for musculoskeletal stability, and an Internet of Things-enabled nebulizer for hygienic drug delivery, integrating advanced diagnostics, wearable medical solutions, and automated treatment systems, enabling healthcare professionals and patients to improve disease management, enhance accessibility to medical care, and optimize treatment outcomes.
Contact Information
Website
trmed.co.krCorporate Office
- Room 510, Daejeon TIPS Town
- 99 Daehak-ro, Yuseong-gu
- Daejeon
- South Korea
Corporate Office
- Room 510, Daejeon TIPS Town
- 99 Daehak-ro, Yuseong-gu
- Daejeon
- South Korea
TR Corporation Timeline
TR Corporation Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 15-May-2026 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series A) | 30-Oct-2025 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 01-Jan-2025 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 01-Jan-2025 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 28-Dec-2023 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 05-May-2022 | Completed | Generating Revenue | |||
| 2. Seed Round | 09-May-2021 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
TR Corporation Patents
TR Corporation Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026160577-A1 | Portable feno tester for asthma diagnosis based on nitric oxide concentration measurement | Pending | 23-Jan-2025 | ||
| WO-2026146929-A1 | Respiratory function diagnosis and monitoring system including respiratory disease tester and method thereof | Pending | 31-Dec-2024 | ||
| JP-2018140884-A | Single crystal production apparatus, and single crystal production method | Active | 25-Feb-2017 | ||
| US-4649974-A | Handbag | Inactive | 29-Aug-1984 | A45C3/08 |
TR Corporation Signals
TR Corporation Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Daewoong Pharmaceutical | Corporation | Minority | ||
| HG Initiative | Impact Investing | Minority | ||
| Naver | Corporation | Minority | ||
| Hallym University Technology Holdings | Venture Capital | Minority | ||
| iAccel (Seongnam-si) | Venture Capital | Minority |
TR Corporation FAQs
-
When was TR Corporation founded?
TR Corporation was founded in 2018.
-
Where is TR Corporation headquartered?
TR Corporation is headquartered in Daejeon, South Korea.
-
What is the size of TR Corporation?
TR Corporation has 23 total employees.
-
What industry is TR Corporation in?
TR Corporation’s primary industry is Therapeutic Devices.
-
Is TR Corporation a private or public company?
TR Corporation is a Private company.
-
What is TR Corporation’s current revenue?
The current revenue for TR Corporation is .
-
How much funding has TR Corporation raised over time?
TR Corporation has raised $1.76M.
-
Who are TR Corporation’s investors?
Daewoong Pharmaceutical, HG Initiative, Naver, Hallym University Technology Holdings, and iAccel (Seongnam-si) are 5 of 17 investors who have invested in TR Corporation.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process